Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 P&G Skincare Patent Details Composition to Inhibit Activation of PAR2 - Happi
Patents

P&G Skincare Patent Details Composition to Inhibit Activation of PAR2

US Patent No. 12,102,707 B2 contains a hydrolysate comprising an aqueous extract of water lily.

Nymphaea alba flowers.

US Patent No. 12,102,707 B2 (Tomohiro Hakozaki, Bin Fang Deyer, Leo Timothy Laughlin, II); Procter & Gamble’s latest skincare patent details compositions for improving the appearance of skin that are suited for inhibiting activation of PAR2 by utilizing a synergistic combination of a water lily extract and a vitamin B3 compound.

The topical composition is comprised of a hydrolysate comprising an aqueous extract of Nymphaea alba flowers and thermally inactivated enzymes, wherein the hydrolysate comprises from about 20-70% carbohydrate, by weight of the dry matter of the hydrolysate; a vitamin B3 compound; and a dermatologically acceptable carrier.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters